Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Anaesthesia is state which induces loss of sensation and awareness in the body, when the several drugs are administered prior surgical procedures. Local anaesthesia promotes the temporary loss of sensation to the specific body part or localized area. They are consumed in order to overcome painful situations, elimination of pain during the major or minor surgical operations along with for minimize post-operative pain. In high doses some of the medicines also act as local anaesthetics. Some of the commonly known used drugs as analgesics are opioid analgesics, anticonvulsant and beta adrenoreceptor antagonists. They are comprised of carbonyl moiety via carbon chain linked for replacement of amino groups. On the carbonyl moiety the local anaesthetics are categorised as amide local anaesthetics and ester local anaesthetics.
The United States local anaesthetic drug market is witnessing rapid growth during the forecast period of 2021 to 2027. The rising adoption of technically updates surgical equipment is gaining attention of United States local anaesthetic drug market. The dynamic factors such as surge in cases to perform surgeries is propelling growth of United States local anaesthetic drug market. Improvement in drug delivery systems is also refuelling growth of United States local anaesthetic drug market. The introduction of new and effective drugs in the market is also elevating growth of United States local anaesthetic drug market. However, side effects associated with drugs and government strict regulations is hampering the growth of United States local anaesthetic drug market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the local anaesthetic drug market. In addition, complete analysis of changes on local anaesthetic drug expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. There is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027.
The United States local anaesthetic drug market is bifurcated by drug molecules, route of administration and distribution channel.
The drug molecules like bupivacaine, lidocaine, benzocaine, ropivacaine, prilocaine, Chloroprocaine and other local anaesthetic drugs are comprised in the United States local anaesthetic drug market. In which Chloroprocaine is also contributing in the growth of United States local anaesthetic drug market. The Chloroprocaine is given by intravenous route and used during labor and delivery. Chloroprocaine is a type of ester anaesthetic which acts by vasodilation in the body. It is also indicated in use of neuraxial anaesthesia (caudal, epidural and spinal) along with peripheral nerve block and obstetric anaesthesia (pudendal and paracervical blocks).
The route of administration like intravenous local anaesthesia, topical local anaesthesia and ophthalmic local anaesthesia are comprised in the United States local anaesthetic drug market. In which topical anaesthesia is also contributing in the growth of United States local anaesthetic drug market. The topical route have certain benefits like high patient comfort, no needle associated pain, risk elimination of local infiltration of local anaesthesia like distortion of wound margin, systemic absorption and toxicity. The ophthalmic local anaesthetic is also contributing in the growth of United States local anaesthetic drug market. They work as integral part of ophthalmology since decades.
The United States local anaesthetic drug market is comprised of online pharmacies, retail pharmacies and hospital pharmacies. In which retail pharmacies are also contributing in the growth of United States local anaesthetic drug market. The retail pharmacies have better understanding of the patient’s current therapy, side effects and medical history of the patient as they maintain the data of patient medical conditions. They also help in spreading awareness about drugs, doses, side effects and adverse effects of medications. The online pharmacies is also contributing in the growth of United States local anaesthetic drug market. As due to COVID-19 pandemic peoples are preferring to order from online pharmacies rather than going outside of home.
The key players operating in the local anaesthetic drug market are Advanced Pharma Inc., Akorn Inc., Aspen Pharmacare, Baxter International Inc., Fresenius Kabi, Glenmark Pharmaceuticals Inc., Mylan, Novartis Ag, Pacira Pharmaceutical, Pfizer Inc., Sagent Pharmaceutical and Teva Pharmaceutical Industries Ltd. among the others.
November 2018: Septodont announced lauching of Dentapen electronic syringe for use of dental anaesthesia.
April 2018: B. Braun Medical Inc. introduced their first FDA- approved local anaesthetic for use in spinal anaesthesia named Clorotekal® which comprised of Chloroprocaine hydrochloride.
• Astrazeneca offers various anaesthetic products in their portfolio like Carbocaine (mepivacaine). Citanest (prilocaine), Dipitan (propofol), EMLA (lidocaine + prilocaine), Marcaine (bupivacaine), Naproin (ropivacaine) and Xylocaine (lidocaine/ lignocaine).
• Glenmark Pharmaceutical offered lidocaine ointment name Fougera for topical anaesthetic purpose comprised of lidocaine ointment USP, 5%.
The study comprised of local anaesthetic drug market. In which different segment of market are analysed. The market segments like drug molecules, route of administrations and distribution channels are analysed in the study. The study also imparts the dominating segments of the market. The drug molecules segment is dominated by lidocaine. Likewise, route of administration segment is dominated by intravenous route and distribution channel is dominated by hospital pharmacies. The study also imparts impact of COVID-19 on local anaesthetic drug market and it concludes that there is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027. The study also analysed various key players operating in the market.
Why to buy this report
